Correlation Between ZyVersa Therapeutics and VIRI Old

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and VIRI Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and VIRI Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ZyVersa Therapeutics and VIRI Old, you can compare the effects of market volatilities on ZyVersa Therapeutics and VIRI Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of VIRI Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and VIRI Old.

Diversification Opportunities for ZyVersa Therapeutics and VIRI Old

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between ZyVersa and VIRI is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and VIRI Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VIRI Old and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with VIRI Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VIRI Old has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and VIRI Old go up and down completely randomly.

Pair Corralation between ZyVersa Therapeutics and VIRI Old

Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the VIRI Old. But the stock apears to be less risky and, when comparing its historical volatility, ZyVersa Therapeutics is 1.12 times less risky than VIRI Old. The stock trades about -0.03 of its potential returns per unit of risk. The VIRI Old is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  974.00  in VIRI Old on November 3, 2024 and sell it today you would lose (700.00) from holding VIRI Old or give up 71.87% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy86.29%
ValuesDaily Returns

ZyVersa Therapeutics  vs.  VIRI Old

 Performance 
       Timeline  
ZyVersa Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ZyVersa Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.
VIRI Old 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VIRI Old has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in March 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

ZyVersa Therapeutics and VIRI Old Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ZyVersa Therapeutics and VIRI Old

The main advantage of trading using opposite ZyVersa Therapeutics and VIRI Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, VIRI Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VIRI Old will offset losses from the drop in VIRI Old's long position.
The idea behind ZyVersa Therapeutics and VIRI Old pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio